FDA Approved: PRETOMANID — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved a supplemental application for Pretomanid, submitted by Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensively Drug-resistant Tuberculosis
• Multidrug-resistant Tuberculosis
• Tuberculosis

Drugs mentioned

• Pretomanid (pretomanid)

Snippet

SUPPL AP for PRETOMANID (PRETOMANID)